Tyra Biosciences, Inc.
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
TYRA$22.30+5.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
EXHIBIT INDEX
| ExhibitNumber · Exhibit Description · Incorporated by Reference · FiledHerewith | ||||
|---|---|---|---|---|
| Form · Date · Number | ||||
| 3.1 | Amended and Restated Certificate of Incorporation | 10-K | 3/22/23 | 3.1 |
| 3.2 | Amended and Restated Bylaws, effective as of October 26, 2023 | 8-K | 10/26/23 | 3.1 |
| 4.1 | Specimen stock certificate evidencing the shares of common stock | S-1 | 8/20/21 | 4.1 |
| 4.2 | Amended and Restated Investors’ Rights Agreement, dated March 5, 2021, by and among the Registrant and certain of its stockholders | S-1/A | 9/9/21 | 4.2 |
| 4.3 | Description of Registered Securities | 10-K | 3/3/22 | 4.3 |
| 4.4 | Form of Pre-Funded Warrant | 8-K | 2/5/24 | 4.1 |
| 10.1# | Tyra Biosciences, Inc. 2020 Equity Incentive Plan and form of stock option agreement thereunder | S-1 | 8/20/21 | 10.1 |
| 10.2# | Tyra Biosciences, Inc. 2021 Incentive Award Plan and form of stock option grant notice and stock option agreement thereunder | S-1/A | 9/9/21 | 10.2 |
| 10.3# | Tyra Biosciences, Inc. 2021 Employee Stock Purchase Plan | S-1/A | 9/9/21 | 10.3 |
| 10.4# | Non-Employee Director Compensation Program, amended and restated effective May 1, 2024 | 10-Q | 5/9/2024 | 10.3 |
| 10.5# | Tyra Biosciences, Inc. Annual Bonus Plan | 10-K | 3/22/23 | 10.5 |
| 10.6# | Second Amended and Restated Employment Letter Agreement, dated August 18, 2021, by and between Todd Harris and the Registrant | S-1 | 8/20/21 | 10.12 |
| 10.7# | Second Amended and Restated Employment Letter Agreement, dated August 18, 2021, by and between Daniel Bensen and the Registrant | S-1 | 8/20/21 | 10.13 |
| 10.8# | Employment Letter Agreement, dated December 31, 2022, by and between Alan Fuhrman and the Registrant | 10-K | 3/22/23 | 10.14 |
| 10.9# | Employment Agreement, dated September 9, 2024, between the Registrant and Douglas Warner, M.D. | 10-Q | 11/7/2024 | 10.2 |
| 10.10# | Transition Agreement, dated August 3, 2024, between the Registrant and Hiroomi Tada, M.D., Ph.D. | 10-Q | 11/7/2024 | 10.1 |
| 10.11# | Form of Indemnification Agreement for Directors and Officers | S-1 | 8/20/21 | 10.20 |
| 10.12 | Office Lease, between the Registrant and Fabric 2656 State, LLC, a California limited liability company, dated August 5, 2020 | S-1 | 8/20/21 | 10.19 |
| 10.13 | First Amendment to Lease, between the Registrant and Fabric 2656 State, LLC, a California limited liability company, dated March 2, 2022 | 10-K | 3/3/22 | 10.14 |
| 10.14 | Second Amendment to Lease, between the Registrant and Fabric 2656 State, LLC, a California limited liability company, dated December 20, 2022 | 10-K | 3/22/23 | 10.19 |
| 10.15 | Office Lease, between the Registrant and Fabric 2676 State Street, LLC, a California limited liability company, dated March 2, 2022 | 10-K | 3/3/22 | 10.15 |
| 10.16 | First Amendment to Lease, between the Registrant and Fabric 2676 State, LLC, a California limited liability company, dated May 16, 2022 | 10-K | 3/22/23 | 10.21 |
| 10.17 | Second Amendment to Lease, between the Registrant and Fabric 2676 State, LLC, a California limited liability company, dated January 6, 2023 | 10-K | 3/22/23 | 10.22 | |
| 10.18 | Third Amendment to Lease, between the Registrant and Fabric 2676 State, LLC, a California limited liability company, dated March 18, 2024 | 10-K | 3/19/2024 | 10.23 | |
| 10.19 | ATM Sales Agreement, dated October 3, 2022, by and between Virtu Americas LLC and the Registrant | 8-K | 10/3/22 | 1.2 | |
| 19.1 | Insider Trading Compliance Policy and Procedures | X | |||
| 23.1 | Consent of Independent Registered Public Accounting Firm | X | |||
| 31.1 | Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | |||
| 31.2 | Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | |||
| 32.1* | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||
| 32.2* | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||
| 97.1 | Policy for Recovery of Erroneously Awarded Compensation | 10-K | 3/19/2024 | 97.1 | |
| 101.INS | Inline XBRL Instance Document - the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | X | |||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL Document) | X | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.